| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/15/2009 | WO2009007222A1 An antibody specific for the tn antigen for the treatment of cancer |
| 01/15/2009 | WO2009007187A1 Substituted 5-hetarylpyrimidines |
| 01/15/2009 | WO2009006839A1 Substituted indol-3-yl oxalylpodophyllotoxin derivates, their salts, and application thereof |
| 01/15/2009 | WO2009006799A1 A pharmaceutical compositon comprising taxanes, the preparation and use thereof |
| 01/15/2009 | WO2008144473A3 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/15/2009 | WO2008144222A3 Triazolyl aminopyrimidine compounds |
| 01/15/2009 | WO2008131267A3 Low calcemic, highly antiproliferative, analogs of calcitriol |
| 01/15/2009 | WO2008124083A3 Aurora kinase modulators and method of use |
| 01/15/2009 | WO2008119790A3 Use of fluoride-containing compounds for diagnostic purposes with the help of imaging processes |
| 01/15/2009 | WO2008113686A3 Photoreactive ru (ii) complexes anchored on oligonucleotides, method for obtaining them and use thereof |
| 01/15/2009 | WO2008109735A3 O6-alkylguanine-dna alkyltransferase inactivators |
| 01/15/2009 | WO2008109532A4 Nucleic acid compounds for inhibiting fas gene expression and uses thereof |
| 01/15/2009 | WO2008100624A3 Antibodies against erbb3 and uses thereof |
| 01/15/2009 | WO2008085951A3 Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells |
| 01/15/2009 | WO2008049904A3 Use of mtki 1 for treating or preventing bone cancer |
| 01/15/2009 | WO2006073202A9 METHOD OF TUMOR SUPPRESSION AND EVALUATION OF ANTICANCER AGENT BASED ON GSK3β INHIBITORY EFFECT |
| 01/15/2009 | WO2006003222A9 Use of formoterol in the prophylactic and/or therapeutic treatment of muscle wasting and/or cachectic syndrome which are associated with catabolic conditions of certain diseases, such as cancer, aids, infections, diabetes and others |
| 01/15/2009 | US20090018357 Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use |
| 01/15/2009 | US20090018342 New epothiolone derivatives, process for their production, and their pharmaceutical use |
| 01/15/2009 | US20090018335 Fused heterocyclic compound |
| 01/15/2009 | US20090018331 Condensed imidazole derivatives |
| 01/15/2009 | US20090018312 Igf-1 receptor interacting proteins |
| 01/15/2009 | US20090018185 Compositions and products containing s-equol, and methods for their making |
| 01/15/2009 | US20090018183 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 01/15/2009 | US20090018177 Propane-1,3-Dione Derivative or Salt Thereof |
| 01/15/2009 | US20090018172 DIPHENYLUREA DERIVATIVES AND THEIR USE AS CHLORIDE CHANNEL BLOCKERS OR BKCa CHANNEL MODULATORS |
| 01/15/2009 | US20090018167 angiogenesis inhibitors such as 1-phenyl-3-pyridin-2-ylprop-2-en-1-one, having antitumor and anticarcinogenic activity; treatment of skin disorders such as psoriasis, acne, rosacea, warts, eczema, hemangiomas, and lymphangiogenesis, as well as chronic inflammatory disease such as arthritis |
| 01/15/2009 | US20090018164 Farnesyl protein transferase inhibitors for treating breast cancer |
| 01/15/2009 | US20090018156 Pyrrolo [2,3,B] Pyridine Derivatives Useful As RAF Kinase Inhibitors |
| 01/15/2009 | US20090018153 antiproliferative; cancer, psoriasis; increased bioavailability |
| 01/15/2009 | US20090018152 Aminophenyl Derivatives as Novel Inhibitors of Histone Deacetylase |
| 01/15/2009 | US20090018146 Combination Therapy with Triterpenoid Compounds and Proteasome Inhibitors |
| 01/15/2009 | US20090018142 Use of phosphatases to treat tumors overexpressing N-CoR |
| 01/15/2009 | US20090018137 Buffer intracellular reduction and oxidation for the stressed cells in various disease states; beneficial as adjunctive support therapy, multiple chemical sensitivity syndrome, Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Roussy-Levy syndrome, Rosenberg Chutorian syndrome, Korsakoff syndrome |
| 01/15/2009 | US20090018134 Compounds - 945 |
| 01/15/2009 | US20090018133 Novel Adamantane Derivatives |
| 01/15/2009 | US20090018131 Quinazoline derivatives as p13 kinase inhibitors |
| 01/15/2009 | US20090018129 compounds that interfere with tyrosine kinase signalling such as 1-{3-Amino-1-methyl-4-[4-(3-phenyl-ureido)-phenyl]-1H-pyrazolo[3,4-b]pyridin-6-yl}-cyclopropanecarboxylic acid ethyl ester, used for the treatment of diseases of dysregulated vascular growth such as retinopathy |
| 01/15/2009 | US20090018120 Amidine derivatives and their applications as a medicament |
| 01/15/2009 | US20090018116 Therapeutic Compounds |
| 01/15/2009 | US20090018099 Protein production |
| 01/15/2009 | US20090018097 Modification of double-stranded ribonucleic acid molecules |
| 01/15/2009 | US20090018096 Methods For Regulating The Growth And/Or Survival Of Tumor Cells And Stem Cells By Modulating The Expression Or Function Of The Transcription Factor ATF5 |
| 01/15/2009 | US20090018088 Treating cancer with cardiac glycosides |
| 01/15/2009 | US20090018086 Monomethylvaline Compounds Having Phenylalanine Side-Chain Replacements at the C-Terminus |
| 01/15/2009 | US20090018085 Use of a GnRH antagonist peptide in the treatment of sex hormone-dependent diseases |
| 01/15/2009 | US20090018083 Methods and compositions for inhibition of bcl6 repression |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018073 Administering polypeptide of growth factor to increase mitogenesis; bind to receptors and increase cell differentiation and survival |
| 01/15/2009 | US20090018069 Methods and Compositions Related to Mutant Kunitz Domain I of Tfpi-2 |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090018062 Malignant tumor-inhibiting preparation comprising des a fibrin |
| 01/15/2009 | US20090018059 Method for maintaining pluripotency of stem/progenitor cells |
| 01/15/2009 | US20090017532 Vector |
| 01/15/2009 | US20090017473 Compositions and methods for the diagnosis and treatment of tumor |
| 01/15/2009 | US20090017117 Pellet formulation for the treatment of the intestinal tract |
| 01/15/2009 | US20090017106 Adjuvants on the basis of bisacyloxypropylcystene conjugates and derivatives and their uses in pharmaceutical compositions |
| 01/15/2009 | US20090017105 Proliposomal and liposomal compositions of poorly water soluble drugs |
| 01/15/2009 | US20090017103 Antisense oligonucleotides for prevention of metastasis formation of cancer cells |
| 01/15/2009 | US20090017076 Treatment for cd5+ b cell lymphoma |
| 01/15/2009 | US20090017060 Cleavable Vaccine Compositions and Uses Thereof and Methods of Making and Using the Same |
| 01/15/2009 | US20090017049 BetaGBP, compositions comprising betaGBP, and related methods and uses thereof |
| 01/15/2009 | US20090017043 Connective tissues growth factor antibodies |
| 01/15/2009 | US20090017037 Human TIMP-1 Antibodies |
| 01/15/2009 | US20090017034 inhibits thymic stromal lymphopoietin TSLP)-mediated lymphocyte stimulation; using these polypeptides as molecular weight markers that allow the estimation of the molecular weight of a protein or a fragmented protein |
| 01/15/2009 | US20090017030 Endothelial Cell Expression Patterns |
| 01/15/2009 | US20090017025 Combinations Comprising a CDK Inhibitor and a Growth Factor Antibody or Anti-Mitotic |
| 01/15/2009 | US20090017024 Methods and Compositions for the Treatment of Cancer, Tumors, and Tumor-Related Disorders |
| 01/15/2009 | US20090017022 Sulfatases and methods of use thereof |
| 01/15/2009 | US20090017021 Methods and compositions for inducing innate immune responses |
| 01/15/2009 | US20090017012 Methods of diagnosing and treating cancer |
| 01/15/2009 | US20090017010 Novel artemis/dna-dependent protein kinase complex and methods of use thereof |
| 01/15/2009 | US20090017009 Method for the diagnosis and prognosis of malignant diseases |
| 01/15/2009 | US20090017003 Thiosulfonate anti-inflammatory agents |
| 01/15/2009 | US20090016989 Antibodies to human somatostatin receptor and methods of use |
| 01/15/2009 | US20090016988 Modified Pore-Forming Protein Toxins and Use Thereof |
| 01/15/2009 | US20090016965 Internal image antibodies for optical imaging and therapy |
| 01/15/2009 | US20090016962 Compositions and methods for the treatment of cancer |
| 01/15/2009 | DE102007033072A1 Erfindung betreffend Expression und permanente Sekretion von caninen Interleukinen Invention on the expression and secretion of permanent canine interleukins |
| 01/15/2009 | DE102007032800A1 Nichtsteroidale Progesteronrezeptor-Modulatoren Non-steroidal progesterone receptor modulators |
| 01/15/2009 | DE102007032739A1 Chinazolinamidderivate Chinazolinamidderivate |
| 01/15/2009 | CA2695039A1 Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt |
| 01/15/2009 | CA2694418A1 Novel antibodies inhibiting c-met dimerization, and uses thereof |
| 01/15/2009 | CA2693455A1 An antibody specific for the tn antigen for the treatment of cancer |
| 01/15/2009 | CA2692977A1 Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders |
| 01/15/2009 | CA2692945A1 Compounds - 945 |
| 01/15/2009 | CA2692786A1 Immunotherapy for hematological malignancies |
| 01/15/2009 | CA2692725A1 Compound - 946 |
| 01/15/2009 | CA2692720A1 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k |
| 01/15/2009 | CA2692653A1 Pyrazolo[1,5-.alpha.]pyridines and their use in cancer therapy |
| 01/15/2009 | CA2692611A1 Di(arylamino)aryl compounds |
| 01/15/2009 | CA2692485A1 Compounds and methods for modulating rho gtpases |
| 01/15/2009 | CA2692234A1 Treatment of melanoma |
| 01/15/2009 | CA2690349A1 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 01/15/2009 | CA2682096A1 Klotho beta |
| 01/14/2009 | EP2015070A1 Novel marker for sensitivity against sulfonamide compound |
| 01/14/2009 | EP2014776A2 Diagnosis of diseases associated with DNA transcription |
| 01/14/2009 | EP2014770A2 WNT-1 Iinduced secreted polypeptide WISP-2 |
| 01/14/2009 | EP2014765A2 A novel species of acrocarpospora, a method of preparing iodinin, and the uses of iodinin |